Zollinger-Ellison syndrome epidemiology and demographics: Difference between revisions
| Line 6: | Line 6: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
Revision as of 20:28, 7 August 2017
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome epidemiology and demographics |
|
FDA on Zollinger-Ellison syndrome epidemiology and demographics |
|
CDC on Zollinger-Ellison syndrome epidemiology and demographics |
|
Zollinger-Ellison syndrome epidemiology and demographics in the news |
|
Blogs on Zollinger-Ellison syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The incidence of gastrinoma, which can cause Zollinger-Ellison syndrome, is approximately 0.05-0.2 per 100,000 individuals worldwide. About 25 to 30 percent of gastrinomas are caused by multiple endocrine neoplasia type 1 (MEN1).
Epidemiology and Demographics
Incidence
- The worldwide incidence of gastrinomas is about 5 to 30 cases per 100,000 individuals per year. With improved techniques for tumor detection, the annual incidence has increased. About 80% to 90% of these tumors arise in the so-called “gastrinoma triangle. [1]
Case Fatality Rate
Age
- Zollinger-Ellison syndrome is a disease that tends to affect the middle-aged adult population (20-50 years of age).[2]
Gender
- Males are more commonly affected with Zollinger-Ellison syndrome than females.[2]
Race
References
- ↑ Cingam S, Karanchi H. PMID 28722872. Missing or empty
|title=(help) - ↑ 2.0 2.1 Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT (2006). "Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature". Medicine (Baltimore). 85 (6): 295–330. doi:10.1097/01.md.0000236956.74128.76. PMID 17108778.